248 related articles for article (PubMed ID: 21867767)
1. RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.
Sharina IG; Cote GJ; Martin E; Doursout MF; Murad F
Nitric Oxide; 2011 Oct; 25(3):265-74. PubMed ID: 21867767
[TBL] [Abstract][Full Text] [Related]
2. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
4. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells.
Sharin VG; Mujoo K; Kots AY; Martin E; Murad F; Sharina IG
Stem Cells Dev; 2011 Jul; 20(7):1287-93. PubMed ID: 20964618
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.
Martin E; Golunski E; Laing ST; Estrera AL; Sharina IG
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1565-75. PubMed ID: 25239802
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor.
Marro ML; Peiró C; Panayiotou CM; Baliga RS; Meurer S; Schmidt HH; Hobbs AJ
J Biol Chem; 2008 Jul; 283(29):20027-36. PubMed ID: 18474600
[TBL] [Abstract][Full Text] [Related]
8. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.
de Frutos S; Nitta CH; Caldwell E; Friedman J; González Bosc LV
Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L475-86. PubMed ID: 19592461
[TBL] [Abstract][Full Text] [Related]
9. Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity.
Sharina IG; Jelen F; Bogatenkova EP; Thomas A; Martin E; Murad F
J Biol Chem; 2008 May; 283(22):15104-13. PubMed ID: 18381288
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.
Bachiller PR; Nakanishi H; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide alters splicing of soluble guanylyl cyclase and selectively modulates expression of splicing regulators in human cancer cells.
Cote GJ; Zhu W; Thomas A; Martin E; Murad F; Sharina IG
PLoS One; 2012; 7(7):e41099. PubMed ID: 22911749
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
[TBL] [Abstract][Full Text] [Related]
13. The G-protein regulator LGN modulates the activity of the NO receptor soluble guanylate cyclase.
Chauhan S; Jelen F; Sharina I; Martin E
Biochem J; 2012 Sep; 446(3):445-53. PubMed ID: 22690686
[TBL] [Abstract][Full Text] [Related]
14. Structure and regulation of soluble guanylate cyclase.
Derbyshire ER; Marletta MA
Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide sensitive-guanylyl cyclase subunit expression changes during estrous cycle in anterior pituitary glands.
Cabilla JP; Ronchetti SA; Nudler SI; Miler EA; Quinteros FA; Duvilanski BH
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E731-7. PubMed ID: 19141686
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
Murthy KS
J Pharmacol Exp Ther; 2008 Apr; 325(1):183-9. PubMed ID: 18180373
[TBL] [Abstract][Full Text] [Related]
17. Efficient expression of human soluble guanylate cyclase in Escherichia coli and its signaling-related interaction with nitric oxide.
Zhong F; Wang H; Ying T; Huang ZX; Tan X
Amino Acids; 2010 Jul; 39(2):399-408. PubMed ID: 20063108
[TBL] [Abstract][Full Text] [Related]
18. Dynamic ligand exchange in soluble guanylyl cyclase (sGC): implications for sGC regulation and desensitization.
Tsai AL; Berka V; Sharina I; Martin E
J Biol Chem; 2011 Dec; 286(50):43182-92. PubMed ID: 22009742
[TBL] [Abstract][Full Text] [Related]
19. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide sensitive guanylyl cyclase activity decreases during cerebral postnatal development because of a reduction in heterodimerization.
Haase N; Haase T; Seeanner M; Behrends S
J Neurochem; 2010 Jan; 112(2):542-51. PubMed ID: 19895661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
